Page 77 - 《中国药房》2024年11期
P. 77
吴茱萸碱对哮喘模型大鼠炎症及上皮细胞凋亡的影响及机制
Δ
1
1
2
1
1 #
1
1*
雷 俊 ,卢丽君 ,罗玲艳 ,乔 松 ,童亚男 ,郑 洋 ,姚 蕾 [1.武汉市中医医院肺系病科,武汉 430014;
2.武汉市第三医院(武汉大学附属同仁医院)急诊医学科,武汉 430014]
中图分类号 R965;R285.5 文献标志码 A 文章编号 1001-0408(2024)11-1351-06
DOI 10.6039/j.issn.1001-0408.2024.11.12
摘 要 目的 探究吴茱萸碱对哮喘模型大鼠炎症反应及上皮细胞凋亡的影响及潜在机制。方法 将SD大鼠分为对照组、模型
组、吴茱萸碱低剂量组(10 mg/kg)、吴茱萸碱高剂量组(20 mg/kg)、地塞米松组(阳性对照,0.5 mg/kg)、表皮细胞生长因子(EGF)组
[丝裂原活化蛋白激酶(MAPK)激活剂,10 μg]、吴茱萸碱高剂量+EGF组(20 mg/kg吴茱萸碱+10 μg EGF),每组10只。除对照组
外,其余各组大鼠以10%卵白蛋白(OVA)-氢氧化铝混合液3点注射致敏联合2%OVA雾化液吸入激发的方式建立哮喘模型。检
测各组大鼠支气管肺泡灌洗液(BALF)中的炎症细胞(巨噬细胞、淋巴细胞)数,观察大鼠肺组织的病理变化,检测大鼠肺组织中气
道上皮细胞凋亡情况、血清炎症因子(肿瘤坏死因子α、白细胞介素6、白细胞介素4)水平、通路相关蛋白[p38 MAPK、磷酸化p38
MAPK(p-p38 MAPK)、信号转导及转录激活因子1(STAT1)]及凋亡相关蛋白[B细胞淋巴瘤2(Bcl-2)、Bcl-2相关X蛋白(Bax)]的
表达水平。结果 与对照组比较,模型组大鼠肺组织可见支气管黏膜水肿、肺泡间隔增厚和大量炎症细胞浸润,炎症细胞数显著增
多;气道上皮细胞凋亡率、炎症因子水平、p-38 MAPK/p-38 MAPK和Bax、STAT1蛋白表达水平均显著升高,Bcl-2蛋白表达水平和
Bcl-2/Bax均显著降低(P<0.05)。与模型组比较,吴茱萸碱低、高剂量组和地塞米松组大鼠肺组织病理改变均有不同程度缓解,上
述各指标均显著逆转,而EGF组上述指标的变化趋势则相反(P<0.05);EGF能显著减弱高剂量吴茱萸碱对哮喘大鼠炎症反应的
改善作用(P<0.05)。结论 吴茱萸碱可减轻哮喘大鼠炎症反应并减少气道上皮细胞凋亡,其作用机制可能与抑制 p38 MAPK/
STAT1信号通路有关。
关键词 吴茱萸碱;哮喘;炎症反应;气道上皮细胞;凋亡;p38 MAPK/STAT1信号通路
Effects of evodiamine on inflammation and apoptosis of airway epithelial cells in asthma model rats and its
mechanism
1
1
1
1
1
LEI Jun ,LU Lijun ,LUO Lingyan ,QIAO Song ,TONG Yanan ,ZHENG Yang ,YAO Lei [1. Dept. of
2
1
Pulmonary Diseases, Wuhan Hospital of Traditional Chinese Medicine, Wuhan 430014, China;2. Dept. of
Emergency Medicine, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan 430014, China]
ABSTRACT OBJECTIVE To explore the effects and potential mechanism of evodiamine on inflammatory response and
apoptosis of epithelial cells in asthma model rats. METHODS SD rats were separated into control group, model group, evodiamine
low-dose group (10 mg/kg), evodiamine high-dose group (20 mg/kg), dexamethasone group (positive control, 0.5 mg/kg),
epidermal growth factor (EGF) group [mitogen-activated protein kinase (MAPK) activator, 10 μg], evodiamine high-dose+EGF
group (20 mg/kg evodiamine+10 μg EGF), with 10 rats in each group. Except for the control group, the other groups were
sensitized by 3-point injection of 10% ovalbumin(OVA)-aluminium hydroxide mixture and stimulated by inhalation of 2%OVA
nebulized liquid to establish an asthma model. The count of inflammatory cells (macrophages and lymphocytes) in bronchoalveolar
lavage fluid (BALF) was detected in each group; pathological changes of lung tissue in rats were observed; the apoptosis of
airway epithelial cells, the levels of serum inflammatory factors [tumor necrosis factor- α, interleukin-6 (IL-6) and IL-4], the
expressions of pathway-related proteins p38 MAPK, phosphorylated p38 MAPK (p-p38 MAPK), signal transduction and
transcription activating factor 1 (STAT1)] and apoptosis-related proteins [B cell lymphoma-2 (Bcl-2) and Bcl-2 associated X
protein (Bax)] were all detected in lung tissue. RESULTS Compared with the control group, bronchial mucosal edema, thickening
of alveolar septa and extensive infiltration of inflammatory cells were observed in the lung tissue of rats in the model group; the
number of inflammatory cells, apoptosis rate of airway epithelial cells, the levels of inflammatory factors, p-38 MAPK/p-38
MAPK, and the protein expressions of Bax and STAT1 were increased significantly; the expressions of Bcl-2 protein and Bcl-2/Bax
were reduced significantly (P<0.05). Compared with the model group, the pathological changes in lung tissues were alleviated to
varying degrees in evodiamine low-dose and high-dose groups, and dexamethasone groups, and the above indicators were
significantly reversed. However, the change trends of
Δ 基金项目 武汉市医学科研项目(No.WZ21C57) corresponding indicators in the EGF group were opposite to
*第一作者 主治医师,硕士。研究方向:中医药防治呼吸系统疾 the above (P<0.05). EGF could significantly attenuate the
病。E-mail:leijlj@163.com effect of high-dose evodiamine on inflammatory response in
# 通信作者 副主任医师,硕士。研究方向:中医药防治呼吸系统 asthmatic rats (P<0.05). CONCLUSIONS Evodiamine can
疾病。E-mail:xiah46581@163.com relieve inflammatory reactions and inhibit the apoptosis of
中国药房 2024年第35卷第11期 China Pharmacy 2024 Vol. 35 No. 11 · 1351 ·